Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 IL17F 1件: Th17 cell differentiation D11550 Bimekizumab 3件: 46, 97, 271
2 MAPK14 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod 2件: 113, 222
3 MAPK14 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod 1件: 8
4 MTOR 4件: Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D00753 Sirolimus 40件: 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331
5 MTOR 4件: Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D02714 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277
6 MTOR 4件: Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D06068 Temsirolimus 1件: 13
7 IFNG 4件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis D04242 Fontolizumab 1件: 46
8 IFNG 4件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis D11120 Emapalumab 3件: 49, 65, 107
9 IFNGR1 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D00747 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326
10 IFNGR2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D00747 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326
11 IL1B 6件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
12 IL1B 6件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D06635 Rilonacept 4件: 51, 106, 107, 266
13 IL1B 6件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09315 Canakinumab 10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269
14 IL1B 6件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09911 Gevokizumab 4件: 41, 50, 56, 269
15 IL1R1 1件: Th17 cell differentiation D02934 Anakinra 18件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299
16 IL2RA 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
17 IL2RA 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D03058 Basiliximab 6件: 2, 50, 66, 97, 222, 228
18 IL2RA 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D03639 Daclizumab 8件: 13, 56, 60, 65, 97, 107, 283, 284
19 IL2RB 3件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation, Transcriptional misregulation in cancer D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
20 IL2RG 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
21 IL4 1件: Th17 cell differentiation D03117 Binetrakin 1件: 46
22 IL4R 1件: Th17 cell differentiation D10354 Dupilumab 5件: 51, 97, 98, 160, 162
23 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
24 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D08976 Pomalidomide 5件: 28, 51, 85, 227, 331
25 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D09669 Siltuximab 2件: 28, 331
26 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D10080 Sirukumab 2件: 41, 46
27 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D12487 Olokizumab 2件: 46, 96
28 IL6R 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D02596 Tocilizumab 21件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331
29 IL6R 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D10161 Sarilumab 5件: 41, 46, 84, 107, 271
30 IL6R 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D11079 Satralizumab 3件: 11, 13, 86
31 IL17A 1件: Th17 cell differentiation D09967 Secukinumab 8件: 13, 37, 41, 46, 107, 160, 269, 271
32 IL17A 1件: Th17 cell differentiation D10071 Ixekizumab 8件: 36, 37, 46, 107, 160, 162, 269, 271
33 IL17A 1件: Th17 cell differentiation D11127 Tibulizumab 1件: 53
34 IL17A 1件: Th17 cell differentiation D11550 Bimekizumab 3件: 46, 97, 271
35 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09959 Ruxolitinib 3件: 60, 65, 228
36 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
37 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10308 Baricitinib 13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
38 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10653 Peficitinib 1件: 46
39 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10871 Filgotinib 6件: 46, 53, 96, 97, 222, 271
40 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10944 Itacitinib 4件: 46, 51, 97, 228
41 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10994 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271
42 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D11400 Abrocitinib 1件: 84
43 JAK2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09959 Ruxolitinib 3件: 60, 65, 228
44 JAK2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
45 JAK2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D10308 Baricitinib 13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
46 JAK2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D10653 Peficitinib 1件: 46
47 JAK3 2件: Th17 cell differentiation, Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
48 JAK3 2件: Th17 cell differentiation, Viral carcinogenesis D10653 Peficitinib 1件: 46
49 LCK 2件: Th17 cell differentiation, Yersinia infection D03658 Dasatinib 2件: 51, 85
50 LCK 2件: Th17 cell differentiation, Yersinia infection D06414 Dasatinib 2件: 51, 85
51 NFKB1 8件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D01146 Iguratimod 5件: 46, 51, 53, 271, 300
52 IL22 1件: Th17 cell differentiation D11953 Efmarodocokin alfa 2件: 96, 97
53 IL23A 2件: Th17 cell differentiation, Tuberculosis D09214 Ustekinumab 16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
54 IL23A 2件: Th17 cell differentiation, Tuberculosis D10400 Tildrakizumab 2件: 162, 271
55 IL23A 2件: Th17 cell differentiation, Tuberculosis D10438 Guselkumab 5件: 37, 41, 51, 96, 97
56 IL23A 2件: Th17 cell differentiation, Tuberculosis D10912 Brazikumab 2件: 96, 97
57 IL23A 2件: Th17 cell differentiation, Tuberculosis D11052 Risankizumab 4件: 37, 96, 97, 271
58 IL23A 2件: Th17 cell differentiation, Tuberculosis D11123 Mirikizumab 3件: 37, 96, 97
59 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
60 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
61 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
62 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
63 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 2件: 49, 222
64 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
65 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
66 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
67 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
68 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 2件: 49, 222
69 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
70 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
71 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
72 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
73 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 2件: 49, 222
74 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
75 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
76 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
77 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
78 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 2件: 49, 222
79 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
80 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
81 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
82 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
83 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 2件: 49, 222
84 PRKCQ 2件: Vascular smooth muscle contraction, Th17 cell differentiation D09671 Sotrastaurin 1件: 97
85 MAPK11 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod 2件: 113, 222
86 MAPK11 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod 1件: 8
87 MAPK13 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod 2件: 113, 222
88 MAPK13 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod 1件: 8
89 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D00094 Tretinoin 6件: 2, 62, 63, 75, 94, 231
90 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D00348 Isotretinoin 4件: 36, 39, 159, 160
91 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D01418 Tamibarotene 2件: 26, 96
92 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D02754 Acitretin 1件: 37
93 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D02815 Alitretinoin 1件: 49
94 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D04162 Fenretinide 1件: 299
95 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D06543 Vitamin A 3件: 13, 53, 90
96 RELA 8件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D12181 Edasalonexent 1件: 113
97 RXRA 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin 1件: 37
98 RXRA 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin 1件: 49
99 RXRA 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene 2件: 13, 75
100 RXRB 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin 1件: 37
101 RXRB 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin 1件: 49
102 RXRB 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene 2件: 13, 75
103 RXRG 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin 1件: 37
104 RXRG 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin 1件: 49
105 RXRG 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene 2件: 13, 75
106 MAPK12 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod 2件: 113, 222
107 MAPK12 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod 1件: 8
108 TGFB1 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09620 Fresolimumab 3件: 51, 85, 222
109 TYK2 2件: Th17 cell differentiation, Toxoplasmosis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
110 TYK2 2件: Th17 cell differentiation, Toxoplasmosis D11817 Deucravacitinib 3件: 49, 96, 97
111 CD3D 1件: Th17 cell differentiation D06314 Visilizumab 2件: 96, 97
112 CD3D 1件: Th17 cell differentiation D08959 Otelixizumab 1件: 46
113 CD3E 1件: Th17 cell differentiation D06314 Visilizumab 2件: 96, 97
114 CD3E 1件: Th17 cell differentiation D08959 Otelixizumab 1件: 46
115 CD3E 1件: Th17 cell differentiation D11463 Mosunetuzumab 1件: 49
116 CD3G 1件: Th17 cell differentiation D06314 Visilizumab 2件: 96, 97
117 CD3G 1件: Th17 cell differentiation D08959 Otelixizumab 1件: 46
118 CD4 4件: Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Th17 cell differentiation, Yersinia infection D06356 Zanolimumab 1件: 46